Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Pisini
Psy46 - A Dynamic Approach for Budget Impact Analysis (Bia) in Oncology – The Case of Novel Treatment Combinations for Frontline Transplant-Ineligible Newly Diagnosed Multiple Myeloma (Tie Ndmm)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy17 - Treatment Regimens for Patients With Newly Diagnosed Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation: A Systematic Literature Review and Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Carfilzomib Weekly Plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03)
Clinical Cancer Research
Cancer Research
Oncology
Novel Therapies in Multiple Myeloma for Newly Diagnosed Nontransplant Candidates
Cancer Journal
Cancer Research
Oncology
A Dynamic Approach for Budget Impact Analysis (BIA) in Oncology: Nonmetastatic Castration-Resistant Prostate Cancer (NMCRPC) as an Illustrative Example
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Bortezomib-Based Regimens Used as Induction in Newly Diagnosed Multiple Myeloma (Ndmm) Patients Eligible for Stem Cell Transplantation (Sct)The Cost-Utility Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Benefit of Continuous Treatment for Responders With Newly Diagnosed Multiple Myeloma in the Randomized FIRST Trial
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Daratumumab in Untreated Newly Diagnosed Multiple Myeloma
Therapeutic Advances in Hematology
Hematology
A Budget Impact Model for the Introduction of Bevacizumab for the Treatment of Newly Diagnosed Glioblastoma Multiforme in the UK
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Front-Line Therapies for Elderly Patients With Transplant-Ineligible Multiple Myeloma and High-Risk Cytogenetics in the Era of Novel Agents
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
